NEUPERT PETER M
Insider CIK 1237566 · ADPT Director · FTRE Chief Executive Officer, Director · QSII Director · LH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2026-08-17 | 2026-08-19 | 15,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2026-08-17 | 2026-08-19 | 15,000 | $6.32 | $94.8K | 255,315 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-17 | 2026-08-19 | 15,000 | $25.23 | $378.4K | 240,315 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-17 | 2026-08-19 | 40,000 | $25.10 | $1.00M | 200,315 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-17 | 2026-08-19 | 69,690 | $25.16 | $1.75M | 130,625 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2026-08-17 | 2026-08-19 | 15,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-17 | 2026-08-19 | 69,690 | $25.16 | $1.75M | 130,625 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-17 | 2026-08-19 | 40,000 | $25.10 | $1.00M | 200,315 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-17 | 2026-08-19 | 15,000 | $25.23 | $378.4K | 240,315 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2026-08-17 | 2026-08-19 | 15,000 | $6.32 | $94.8K | 255,315 | SEC↗ |
| FTRE Fortrea Holdings Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 12,852 | — | $0 | 12,852 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise deriv | 2026-05-14 | 2026-05-18 | 148,536 | — | $0 | 0 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise | 2026-05-14 | 2026-05-18 | 148,536 | — | $0 | 246,668 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2026-03-04 | 2026-03-06 | 15,625 | — | $0 | 240,315 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 13,784 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| FTRE Fortrea Holdings Inc. | P Buy | 2025-08-11 | 2025-08-11 | 32,500 | $6.26 | $203.4K | 98,132 | SEC↗ |
| FTRE Fortrea Holdings Inc. | P Buy | 2025-08-08 | 2025-08-11 | 30,000 | $6.79 | $203.7K | 65,632 | SEC↗ |
| FTRE Fortrea Holdings Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 148,536 | — | $0 | 148,536 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise deriv | 2025-05-14 | 2025-05-16 | 7,282 | — | $0 | 0 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise | 2025-05-14 | 2025-05-16 | 7,282 | — | $0 | 35,632 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2025-03-10 | 2025-03-12 | 50,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2025-03-10 | 2025-03-12 | 50,000 | $4.07 | $203.5K | 234,690 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2025-03-10 | 2025-03-12 | 10,000 | $7.05 | $70.5K | 224,690 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2025-03-04 | 2025-03-06 | 23,726 | — | $0 | 23,726 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2025-03-04 | 2025-03-06 | 15,394 | — | $0 | 184,690 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2025-02-11 | 2025-02-13 | 897 | — | $0 | 897 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise deriv | 2025-02-06 | 2025-02-10 | 944 | — | $0 | 0 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise | 2025-02-06 | 2025-02-10 | 944 | — | $0 | 12,887 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise deriv | 2024-07-18 | 2024-07-19 | 6,354 | — | $0 | 7,282 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise | 2024-07-18 | 2024-07-19 | 6,354 | — | $0 | 28,350 | SEC↗ |
| FTRE Fortrea Holdings Inc. | A Award deriv | 2024-05-14 | 2024-05-16 | 7,282 | — | $0 | 13,636 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2024-03-12 | 2024-03-13 | 15,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2024-03-12 | 2024-03-13 | 15,000 | $0.84 | $12.6K | 169,296 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2024-03-04 | 2024-03-06 | 48,044 | — | $0 | 48,044 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2024-03-04 | 2024-03-06 | 31,328 | — | $0 | 154,296 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2024-02-07 | 2024-02-08 | 947 | — | $0 | 944 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2024-02-07 | 2024-02-08 | 947 | — | $0 | 11,943 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2024-02-06 | 2024-02-08 | 944 | — | $0 | 1,891 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2023-12-13 | 2023-12-15 | 100,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2023-12-13 | 2023-12-15 | 100,000 | $0.84 | $84.0K | 122,968 | SEC↗ |
| FTRE Fortrea Holdings Inc. | P Buy | 2023-08-23 | 2023-08-23 | 11,000 | $25.30 | $278.3K | 21,996 | SEC↗ |
| FTRE Fortrea Holdings Inc. | A Award deriv | 2023-07-18 | 2023-07-19 | 6,354 | — | $0 | 6,354 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2023-03-06 | 2023-03-08 | 23,329 | — | $0 | 23,329 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2023-03-06 | 2023-03-08 | 14,775 | — | $0 | 22,968 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2023-02-11 | 2023-02-14 | 742 | — | $0 | 849 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2023-02-11 | 2023-02-14 | 742 | — | $0 | 10,996 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2023-02-07 | 2023-02-09 | 849 | — | $0 | 1,591 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | P Buy | 2022-02-16 | 2022-02-18 | 600 | $264.57 | $158.7K | 10,254 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | P Buy | 2022-02-16 | 2022-02-18 | 1,600 | $263.98 | $422.4K | 9,654 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | P Buy | 2022-02-16 | 2022-02-18 | 1,300 | $262.85 | $341.7K | 8,054 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2022-02-11 | 2022-02-15 | 742 | — | $0 | 742 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2022-02-02 | 2022-02-04 | 771 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2022-02-02 | 2022-02-04 | 771 | — | $0 | 6,754 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2022-01-26 | 2022-01-28 | 16,722 | — | $0 | 16,722 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2022-01-26 | 2022-01-28 | 6,689 | — | $0 | 8,193 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2021-02-14 | 2021-02-17 | 3,759 | — | $0 | 3,759 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2021-02-14 | 2021-02-17 | 1,504 | — | $0 | 1,504 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2021-02-04 | 2021-02-08 | 986 | — | $0 | 771 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2021-02-04 | 2021-02-08 | 986 | — | $0 | 10,982 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2021-02-02 | 2021-02-04 | 771 | — | $0 | 1,757 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2020-02-13 | 2020-02-18 | 8,888 | — | $0 | 8,888 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2020-02-12 | 2020-02-14 | 1,227 | — | $0 | 986 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2020-02-12 | 2020-02-14 | 1,227 | — | $0 | 9,996 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2020-02-04 | 2020-02-06 | 986 | — | $0 | 2,213 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2019-02-12 | 2019-02-14 | 1,227 | — | $0 | 1,227 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2019-02-12 | 2019-02-14 | 1,038 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2019-02-12 | 2019-02-14 | 1,038 | — | $0 | 8,769 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2018-02-12 | 2018-02-14 | 1,038 | — | $0 | 1,038 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2018-02-07 | 2018-02-09 | 1,263 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2018-02-07 | 2018-02-09 | 1,263 | — | $0 | 7,731 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2017-02-09 | 2017-02-13 | 1,560 | — | $0 | 1,263 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2017-02-09 | 2017-02-13 | 1,560 | — | $0 | 6,468 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2017-02-07 | 2017-02-09 | 1,263 | — | $0 | 2,823 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2016-03-11 | 2016-03-15 | 1,237 | — | $0 | 1,560 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2016-03-11 | 2016-03-15 | 1,237 | — | $0 | 4,908 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2016-02-09 | 2016-02-11 | 1,560 | — | $0 | 2,797 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2015-03-11 | 2015-03-13 | 1,237 | — | $0 | 1,237 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2015-02-10 | 2015-02-12 | 1,503 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2015-02-10 | 2015-02-12 | 1,503 | — | $0 | 3,671 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2014-05-13 | 2014-05-15 | 1,503 | — | $0 | 1,503 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2014-05-08 | 2014-05-12 | 1,593 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2014-05-08 | 2014-05-12 | 1,593 | $98.96 | $157.6K | 2,168 | SEC↗ |
| QSII QUALITY SYSTEMS, INC | A Award | 2013-08-15 | 2013-08-19 | 3,836 | — | $0 | 5,836 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2013-05-08 | 2013-05-16 | 1,593 | — | $0 | 1,593 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award | 2013-01-02 | 2013-01-16 | 575 | — | $0 | 575 | SEC↗ |